世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035259

緑膿菌感染症治療の世界市場レポート(2023年)

The Business Research Company

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2023

発刊日 2023/05/16

言語英語

体裁PDF/250ページ

ライセンス/価格250ページ

0000035259

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、緑膿菌感染症治療の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている緑膿菌感染症治療市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 薬剤別
      ◇ 単剤療法
      ◇ 併用療法
    ➣ 薬剤クラス別
      ◇ アミノグリコシド
      ◇ セファロスポリン
      ◇ カルバペネム
      ◇ モノバクタム
      ◇ その他の薬剤クラス
    ➣ 投与経路別
      ◇ 経鼻薬
      ◇ 経口薬
      ◇ 静脈内注入
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
  • 調査企業
    ➣ AbbVie Inc.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Merck & Co. Inc.
    ➣ Janssen Pharmaceutica NV
    ➣ Pfizer Inc.
  • 調査国
    ➣ オーストラリア
    ➣ ブラジル
    ➣ 中国
    ➣ フランス
    ➣ ドイツ
    ➣ インド
    ➣ インドネシア
    ➣ 日本
    ➣ ロシア
    ➣ 韓国
    ➣ イギリス
    ➣ アメリカ
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Pseudomonas Aeruginosa Infection Treatment Market Characteristics

3. Pseudomonas Aeruginosa Infection Treatment Market Trends And Strategies

4. Pseudomonas Aeruginosa Infection Treatment Market - Macro Economic Scenario
4.1. COVID-19 Impact On Pseudomonas Aeruginosa Infection Treatment Market
4.2. Ukraine-Russia War Impact On Pseudomonas Aeruginosa Infection Treatment Market
4.3. Impact Of High Inflation On Pseudomonas Aeruginosa Infection Treatment Market

5. Pseudomonas Aeruginosa Infection Treatment Market Size And Growth
5.1. Global Pseudomonas Aeruginosa Infection Treatment Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Pseudomonas Aeruginosa Infection Treatment Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Pseudomonas Aeruginosa Infection Treatment Market Segmentation
6.1. Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Monotherapy
Combination Therapy
6.2. Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Aminoglycoside
Cephalosporin
Carbapenem
Monobactum
Other Drug Classess
6.3. Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Nasal
Oral
Intravenous
6.4. Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Pseudomonas Aeruginosa Infection Treatment Market Regional And Country Analysis
7.1. Global Pseudomonas Aeruginosa Infection Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Pseudomonas Aeruginosa Infection Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market
8.1. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Pseudomonas Aeruginosa Infection Treatment Market
9.1. China Pseudomonas Aeruginosa Infection Treatment Market Overview
9.2. China Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Pseudomonas Aeruginosa Infection Treatment Market
10.1. India Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Pseudomonas Aeruginosa Infection Treatment Market
11.1. Japan Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Pseudomonas Aeruginosa Infection Treatment Market
12.1. Australia Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Pseudomonas Aeruginosa Infection Treatment Market
13.1. Indonesia Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Pseudomonas Aeruginosa Infection Treatment Market
14.1. South Korea Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Pseudomonas Aeruginosa Infection Treatment Market
15.1. Western Europe Pseudomonas Aeruginosa Infection Treatment Market Overview
15.2. Western Europe Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Pseudomonas Aeruginosa Infection Treatment Market
16.1. UK Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Pseudomonas Aeruginosa Infection Treatment Market
17.1. Germany Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Pseudomonas Aeruginosa Infection Treatment Market
18.1. France Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Pseudomonas Aeruginosa Infection Treatment Market
19.1. Eastern Europe Pseudomonas Aeruginosa Infection Treatment Market Overview
19.2. Eastern Europe Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Pseudomonas Aeruginosa Infection Treatment Market
20.1. Russia Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Pseudomonas Aeruginosa Infection Treatment Market
21.1. North America Pseudomonas Aeruginosa Infection Treatment Market Overview
21.2. North America Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Pseudomonas Aeruginosa Infection Treatment Market
22.1. USA Pseudomonas Aeruginosa Infection Treatment Market Overview
22.2. USA Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Pseudomonas Aeruginosa Infection Treatment Market
23.1. South America Pseudomonas Aeruginosa Infection Treatment Market Overview
23.2. South America Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Pseudomonas Aeruginosa Infection Treatment Market
24.1. Brazil Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Pseudomonas Aeruginosa Infection Treatment Market
25.1. Middle East Pseudomonas Aeruginosa Infection Treatment Market Overview
25.2. Middle East Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Pseudomonas Aeruginosa Infection Treatment Market
26.1. Africa Pseudomonas Aeruginosa Infection Treatment Market Overview
26.2. Africa Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Pseudomonas Aeruginosa Infection Treatment Market Competitive Landscape And Company Profiles
27.1. Pseudomonas Aeruginosa Infection Treatment Market Competitive Landscape
27.2. Pseudomonas Aeruginosa Infection Treatment Market Company Profiles
27.2.1. AbbVie Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Teva Pharmaceutical Industries Ltd.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Merck & Co. Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Janssen Pharmaceutica NV
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Pfizer Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Pseudomonas Aeruginosa Infection Treatment Market

29. Pseudomonas Aeruginosa Infection Treatment Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. The Business Research Company
30.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7: Global Pseudomonas Aeruginosa Infection Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8: Global Pseudomonas Aeruginosa Infection Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9: Asia-Pacific, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10: Asia-Pacific, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11: China, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12: China, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13: India, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14: India, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15: Japan, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16: Japan, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17: Australia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18: Australia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19: Indonesia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20: Indonesia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21: South Korea, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22: South Korea, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23: Western Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24: Western Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25: UK, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26: UK, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27: Germany, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28: Germany, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29: France, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30: France, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31: Eastern Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32: Eastern Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33: Russia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34: Russia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35: North America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36: North America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37: USA, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38: USA, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39: South America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40: South America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41: Brazil, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42: Brazil, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43: Middle East, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44: Middle East, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45: Africa, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46: Africa, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 47: AbbVie Inc. Financial Performance
Table 48: Teva Pharmaceutical Industries Ltd. Financial Performance
Table 49: Merck & Co. Inc. Financial Performance
Table 50: Janssen Pharmaceutica NV Financial Performance
Table 51: Pfizer Inc. Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6: Global Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7: Global Pseudomonas Aeruginosa Infection Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8: Global Pseudomonas Aeruginosa Infection Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9: Asia-Pacific, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10: Asia-Pacific, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11: China, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12: China, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13: India, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14: India, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15: Japan, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16: Japan, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17: Australia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18: Australia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19: Indonesia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20: Indonesia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21: South Korea, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22: South Korea, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23: Western Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24: Western Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25: UK, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26: UK, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27: Germany, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28: Germany, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29: France, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30: France, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31: Eastern Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32: Eastern Europe, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33: Russia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34: Russia, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35: North America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36: North America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37: USA, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38: USA, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39: South America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40: South America, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41: Brazil, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42: Brazil, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43: Middle East, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44: Middle East, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45: Africa, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Medication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46: Africa, Pseudomonas Aeruginosa Infection Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 47: AbbVie Inc. Financial Performance
Figure 48: Teva Pharmaceutical Industries Ltd. Financial Performance
Figure 49: Merck & Co. Inc. Financial Performance
Figure 50: Janssen Pharmaceutica NV Financial Performance
Figure 51: Pfizer Inc. Financial Performance

この商品のレポートナンバー

0000035259

TOP